We sat down for an iso chat with Adjunct Professor of Law and public health policy expert David Sweanor to talk about all things tobacco harm reduction and all things trust in government.
It's more important than ever that governments and health authorities base their policies on evidence, not ideology.
That's particularly concerning for the more than 1 billion smokers worldwide who are at higher risk of a getting a serious case of COVID-19. After months or years of a nicotine habit, quitting now may not help a smoker's odds when it comes to the present danger. And yet, the crisis is serving as a wake-up call for many to pay better attention to their health.
As a result, smoking cessation startups are among the healthcare companies seeing their business improve since the outbreak started. [...]
The COVID-19 pandemic is single handedly changing the face of day-to-day life. Their needs to be some clarification of how public health should respond to the crisis of the outbreak via policy.
The regulation of electronic cigarettes during a pandemic is an interesting case study. Public health departments have warned against the use of inhalants that combust or even aerosolize compounds into a human’s lungs as a means to reduce the risks of the novel coronavirus further.
[...] Less than two hours before Trump took to the podium, Jerome Adams was speaking to a sparsely attended room at the Society for Research on Tobacco and Nicotine's (SRNT) annual conference.
SRNT is one of the biggest tobacco control conferences in the world. Academics, government officials, and nonprofits share research and ideas, mostly on how to regulate or ban nicotine products. A majority of registrants failed to show up, citing fears of contracting or spreading COVID-19. But Adams was clear: Even amid a global pandemic, regulating tobacco can't be ignored.
BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for COVID-19 and is now in pre-clinical testing. If testing goes well, BAT is hopeful that, with the right partners and support from government agencies, between 1 and 3 million doses of the vaccine could be manufactured per week, beginning in June.
While KBP remains a commercial operation, the intention is that its work around the COVID-19 vaccine project will be carried out on a not for profit basis.
Marc Morano is quite simply the world’s number one climate contrarian, a dogged opponent of hysterical science, and a denier of the prophecies of climate doom. In this episode of RegWatch, Morano joins to discuss the crisis in science that many have recognized with regard to vaping and are now becoming aware of due to the disastrous, catastrophic, overreaction to COVID19 by the scientific community and public health agencies the world over.
It lies in the delivery of nicotine. The methodology of nicotine consumption is the main difference between smoking and vaping. Smoking delivers nicotine to the body by burning tobacco. Its impact varies from person to person depending upon one’s weight, size, and health history. However, it is essential to note that burning tobacco has no safe levels.
On the other hand, vaping delivers nicotine by heating an e-liquid and transforming it into vapor. [...]
Just days after the National Disaster Act outlawed the sale of cigarettes during our three-week lockdown period, the Western Cape government have relaxed this law almost entirely. They have confirmed on Wednesday that smokers will be allowed to get their ciggies, but there’s a small caveat… After the ban on purchasing cigarettes was lifted in several local districts, the entire Western Cape has decided to follow suit. A recently released statement explains that smokers can indeed get their fix, but they must only purchase tobacco if they’re also shopping for essential goods. [...]
A college friend who is now a physician first introduced me to an electronic cigarette in 2008. He purchased his online from China with the hope of transitioning from smoking to vaping but found himself using both instead. A few years later, he shared a pleasant surprise -- he had succeeded in quitting both vaping and smoking. [...] Smoking has many negative effects on respiratory health, and the possibility of a relationship between smoking (both traditional cigarettes and marijuana) or vaping with Covid-19 were raised by early observations in China. [...]
British American Tobacco, the maker of brands including Lucky Strike, Dunhill, Rothmans and Benson & Hedges, has said it has a potential coronavirus vaccine in development using tobacco plants. Dr David O’Reilly, the director of scientific research at BAT, said: “Vaccine development is challenging and complex work but we believe we have made a significant breakthrough with our tobacco plant technology platform, and we stand ready to work with governments and all stakeholders to help win the war against Covid-19.
U.S. business regulators are suing to break up the multibillion-dollar deal between tobacco giant Altria and e-cigarette startup Juul Labs, saying their partnership amounted to an agreement not to compete in the U.S. vaping market.
The action announced late Wednesday by the Federal Trade Commission is the latest legal headwind against Altria's investment in the embattled vaping company. Juul sales have been sliding for months amid state and federal investigations, lawsuits and flavor restrictions aimed at curbing the recent explosion in teen vaping.
Big Tobacco is one of the sectors that’s sticking to its forecasts as the coronavirus outbreak hardly dents cigarette demand — and may be leading to smokers lighting up on the job when they work at home. Imperial Tobacco, the maker of Kool cigarettes, said Tuesday the outbreak has had no material impact on its business and that current trading remains in line with expectations. British American Tobacco, whose brands include Lucky Strike and Kent, said something similar two weeks ago, when it reiterated its 2020 guidance. [...]
Smokers who received smoking cessation counseling and used electronic cigarettes (e-cigarettes) containing nicotine were more than twice as likely to successfully quit smoking compared with those who received counseling but did not use e-cigarettes, according to results of a Late-Breaking Clinical Trial presented March 30 at ACC.20/WCC.
While panic and concern about vaping keeps spreading across the US due to the EVALI outbreak and concerns about teen vaping, British medical and health authorities, including the National Health Service and Public Health England, have fully endorsed vaping as a smoking cessation method and keep urging smokers to switch to e-cigarettes.
Sadly, this positive stance is still not rubbing off on the UK public as intended. The survey sought to identify the UK public’s views on using e-cigarettes as a smoking-cessation tools, and whether they believe that the devices have a public-health benefit.
The annual Vapril campaign to help smokers switch to vaping launched yesterday (1 April).
The digitally-focused 2020 campaign seeks to address consumer “misinformation” about vaping with “evidence-backed advice and information”.
It follows last month’s evidence update on the UK e-cigarette market by Public Health England (PHE) which revealed that 37% of smokers had never tried vaping and that over half of them wrongly believed it to be equally or more harmful than smoking. PHE continues to highlight that regulated nicotine vaping is at least 95% less harmful than conventional smoking.
During a recent walk outside of the confines of my COVID-19 quarantine in Baltimore, I passed by someone resting on their marble front steps. As our eyes met, I could sense our shared heaviness, confirmed through our silent nods. An all-too-common exchange these days. The woman lit her cigarette, took a deep drag and exhaled. And I exhaled too.
I don’t enjoy smoking all that much, with the exception of a cigarette or two a year. Ideally on a summer patio. [...]
As new data and studies are emerging on the SARS-CoV-2, we will be constantly upgrading technical information. The present upgrade incorporates information on (1) more recent misinformation (Bloomberg News), (2) new data on COVID-19 vs smoking and (3) more information on environmental vapor
Join Dr. Marewa Glover and tobacco harm reduction journalist Michael McGrady as they discuss the exploitation of the COVID-19 pandemic as a means to implement prohibition measures for restricting tobacco and alcohol access across the nation of New Zealand in a new interview. [...]
Sales of traditional cigarettes have picked up with the issuing of stay-at-home orders related to the COVID-19 pandemic, tobacco industry analysts said Tuesday. For the week that ended March 22, traditional cigarettes sales volume rose 1.1%, according to Piper Sandler & Co. analysts. By comparison, the industry experienced an 8.2% decline for the week that ended March 1. “We believe these higher retail sales likely reflect stock-piling from COVID-19,” Piper Sandler analyst Michael Lavery said.